Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug BP1.4979 aims to calm shaky hands

NCT ID NCT07074002

Symptom relief Sponsor: Bioprojet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a new drug called BP1.4979 can reduce tremors in adults with essential tremor, a condition causing uncontrollable shaking. About 50 participants will take either the drug or a placebo twice daily for 4 weeks. Researchers will check tremor severity and safety through clinic visits and weekly diaries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female ≥18-85 years old * Confirmed diagnosis of ET, characterized by meeting the following criteria: (a) the presence of a bilateral upper limb action tremor that occurs in isolation; (b) a minimum duration of 3 years; and (c) the tremor may or may not be present in other areas such as the voice, or lower limbs * ET characterized by a TETRAS-P score of at least 1.5 in either the forward posture, wing beating posture, or finger-to-nose movement of at least one upper extremity * Female patient: post-menopausal woman having at least 12 months of natural amenorrhea without any alternative medical cause, or woman of childbearing potential using a highly effective method of contraception for the duration of the trial and for 1 month after stopping the investigational medication Exclusion Criteria: * Severe tremor, defined as patient with ET characterized by a TETRAS-P score of ≥ 3 in either the forward posture, wing beating posture, or finger-to-nose movement of at least one upper extremity, or tremor of trunk * Isolated head tremor not accompanied with tremor of any other body part * Medical history or clinical evidence of any other conditions, whether medical, neurological, or psychiatric, that could potentially explain or contribute to the presence of tremors * Patient who takes a medication which may induce tremor * Direct or indirect injury or trauma to the nervous system within 3 months before the onset of tremor * Concomitant treatment with more than three drugs to treat ET * Any prior procedures for the treatment of ET such as deep brain stimulation, brain lesioning, or magnetic resonance (MR)-guided procedures, including MR-guided focused ultrasound

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Essential tremor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

essential tremor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Essential tremor

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Nancy - Hôpital Central

    ACTIVE_NOT_RECRUITING

    Nancy, 54035, France

  • CHU Amiens-Picardie

    ACTIVE_NOT_RECRUITING

    Amiens, 80054, France

  • CHU Besançon

    NOT_YET_RECRUITING

    Besançon, 25030, France

  • CHU Henri Mondor

    ACTIVE_NOT_RECRUITING

    Créteil, 94010, France

  • CHU Poitiers

    ACTIVE_NOT_RECRUITING

    Poitiers, 86000, France

  • CHU Purpan - Bâtiment Pierre Paul Riquet

    RECRUITING

    Toulouse, 31059, France

  • CHU Rennes - CHU Pontchaillou

    ACTIVE_NOT_RECRUITING

    Rennes, 35033, France

  • CHU de Clermont-Ferrand - Hôpital Gabriel Montpied

    ACTIVE_NOT_RECRUITING

    Clermont-Ferrand, 63003, France

  • CHU de Lille - Hôpital Roger SALENGRO

    ACTIVE_NOT_RECRUITING

    Lille, 59037, France

  • CHU de Nice - Hôpital Pasteur 2

    ACTIVE_NOT_RECRUITING

    Nice, 06000, France

  • CHU de Nîmes

    ACTIVE_NOT_RECRUITING

    Nîmes, 30029, France

  • Centre Hospitalier Régional De Marseille - Hôpital de la Timone

    ACTIVE_NOT_RECRUITING

    Marseille, 13005, France

  • Hospices Civils De Lyon Hôpital Neurologique Pierre Wertheimer

    RECRUITING

    Bron, 69500, France

  • Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre

    NOT_YET_RECRUITING

    Strasbourg, 67098, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.